Sialic Acid-Functionalized Iron-Based MetalβOrganic Framework Nanoprobe for Tumor-Targeted Near-Infrared Fluorescence/Magnetic Resonance Imaging of Cervical Cancer
9 September 2026 at 01:00
Abstract
Accurate localization and delineation of cervical cancer
lesions
are essential for precise surgical planning. However, conventional
magnetic resonance imaging (MRI) often provides insufficient molecular
specificity for tumor delineation, whereas near-infrared fluorescence
(NIRF) imaging is restricted by shallow tissue penetration. Herein,
we developed a sialic acid (N-Acetylneuraminic acid, Neu5Ac)-functionalized
nanoscale iron-based metalβorganic framework (MOF) nanoprobe,
NH2-MIL-101(Fe)/Neu5Ac/Cy7, for tumor-targeted NIRF/MR
dual-modal imaging of cervical cancer. The nanoscale Fe-MOF framework
provides intrinsic T2-weighted MR contrast and serves as
a functional scaffold for PEG/Neu5Ac surface modification and Cy7
loading. In SiHa cells, the Neu5Ac-functionalized nanoprobe exhibited
approximately 2.1-fold and 3.9-fold higher intracellular fluorescence
than the non-Neu5Ac-modified counterpart at 8 and 12 h, respectively.
Time-dependent in vivo NIRF imaging further identified
8 h postinjection as a suitable imaging time point. In SiHa tumor-bearing
mice, NH2-MIL-101(Fe)/Neu5Ac/Cy7 showed enhanced tumor-associated
accumulation compared with control probes, as evidenced by pronounced
T2-weighted MR signal attenuation and a 4.36-fold higher ex vivo tumor fluorescence intensity than the non-Neu5Ac-modified
counterpart. Collectively, this nanoscale dual-modal imaging platform
combines MRI-based deep-tissue localization with NIRF imaging sensitivity,
offering a promising strategy for cervical cancer lesion visualization
and tumor-region delineation.